Breakthrough Chemistry, Inc. (BKTH)
0.095
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Breakthrough Chemistry Net Income (Quarterly) : -1.083M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.083M |
| March 31, 2026 | 0.0792M |
| December 31, 2025 | 1.402M |
| September 30, 2025 | -0.0196M |
| June 30, 2025 | -0.0187M |
| March 31, 2024 | -0.0348M |
| December 31, 2023 | -0.0748M |
| September 30, 2023 | -0.0063M |
| June 30, 2023 | -0.0267M |
| March 31, 2023 | -0.0965M |
| December 31, 2022 | -0.0296M |
| September 30, 2022 | -0.0023M |
| June 30, 2022 | -0.0408M |
| March 31, 2022 | -0.0347M |
| December 31, 2021 | -0.0373M |
| September 30, 2021 | -0.0731M |
| June 30, 2021 | -0.0182M |
| March 31, 2021 | -0.0066M |
| December 31, 2020 | -0.2193M |
| September 30, 2020 | 41.37M |
| June 30, 2020 | -22.99M |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | -0.0001M |
| January 31, 2014 | 0.00 |
| Date | Value |
|---|---|
| October 31, 2013 | -0.03M |
| July 31, 2013 | -0.43M |
| April 30, 2013 | 0.00 |
| January 31, 2013 | 0.00 |
| October 31, 2012 | 0.00 |
| July 31, 2012 | -0.0045M |
| April 30, 2012 | 0.00 |
| January 31, 2012 | 0.1498M |
| October 31, 2011 | -0.0348M |
| July 31, 2011 | -0.1559M |
| April 30, 2011 | -0.0503M |
| January 31, 2011 | -0.0517M |
| October 31, 2010 | -0.086M |
| July 31, 2010 | -1.618M |
| April 30, 2010 | -0.1371M |
| January 31, 2010 | -0.0734M |
| October 31, 2009 | -0.128M |
| July 31, 2009 | -0.1752M |
| April 30, 2009 | -0.1393M |
| January 31, 2009 | 0.2788M |
| October 31, 2008 | -0.2224M |
| July 31, 2008 | -0.1228M |
| April 30, 2008 | -0.1456M |
| January 31, 2008 | -0.1806M |
| October 31, 2007 | -0.0878M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | -0.1372M |
| Precision Optics Corp., Inc. | -0.1038M |
| Petros Pharmaceuticals, Inc. | -0.9556M |
| RxSight, Inc. | -12.10M |
| Vyome Holdings, Inc. | -0.7197M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0025M |
| Total Expenses (Quarterly) | 1.085M |
| EPS Diluted (Quarterly) | -0.1113 |
| Enterprise Value | 0.2897M |
| Profit Margin (Quarterly) | -43.31K% |
| Earnings Yield | -107.1% |
| Normalized Earnings Yield | -36.63 |